 Navin Fluorine International Ltd approves capex
Navin Fluorine International Ltd approves capex Purest gold, silver products in 10 minutes: MMTC-PAMP partners with Swiggy Instamart
Purest gold, silver products in 10 minutes: MMTC-PAMP partners with Swiggy Instamart Cosmo Plastech Expands Rigid Packaging Solutions for the Pharmaceutical Industry with PET Sheets
Cosmo Plastech Expands Rigid Packaging Solutions for the Pharmaceutical Industry with PET Sheets IPO Note - Lenskart Solutions Ltd - Reliance Securities
IPO Note - Lenskart Solutions Ltd - Reliance Securities IndiGo expands its Middle East footprint with new Bengaluru-Riyadh direct flights, starting 16 November 2025
IndiGo expands its Middle East footprint with new Bengaluru-Riyadh direct flights, starting 16 November 2025 
              Ankur Drugs & Pharma Ltd has announced that a meeting of the Board of Directors of the Company will be held on April 28, 2007, inter alia, to transact the following:
1. To Consider issuing of Equity Shares and Fully Convertible Bonds / Debentures - on Preferential Basis and Foreign Currency Convertible Bonds or such other similar convertible securities to the extent of USD 30 millions to Institutional Investors, Mutual Funds and FIIs.
2. To Induct Dr. Clifton Zimmermann on the Board.
The stock closed the day at Rs.254.60, down by Rs.5.35 or 2.06%. The stock hit an intraday high of Rs.264.90 and low of Rs.251.60. The total traded quantity was 39841 compared to 2 week average of 50498.